Search all trials

Find therapies in clinical trials near you – page 30

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Malignant melanoma stage IV+1

Not recruiting

Registered drugNo placebo

Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Small cell lung cancer extensive stage+2

Not recruiting

InvestigationalNo placebo

Testing Tarlatamab in Patients with Advanced Small-Cell Lung Cancer Who Have Poor Physical Condition

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Tarlatamab

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Acasunlimab

Contact Research Centre

Chronic kidney disease+1

Not recruiting

Investigational

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Ziltivekimab

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Rocatinlimab

Contact Research Centre

Major depression

Not recruiting

Investigational

Study of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Lavender Oil

Contact Research Centre

Metabolic dysfunction-associated liver disease+2

Not recruiting

Registered drug

Comparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease

Registered drug

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Endocrine ophthalmopathy

Not recruiting

Investigational

Study of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:AMG 732

Contact Research Centre

Fabry's disease

Not recruiting

Registered drugNo placebo

Study comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:AGALSIDASE BETA

Contact Research Centre

Urticaria chronic

Not recruiting

Investigational

Study of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria

Investigational

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Adenocarcinoma gastric+3

Not recruiting

Registered drug

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Hereditary angioedema

Not recruiting

InvestigationalNo placebo

Safety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Garadacimab

Contact Research Centre

Find therapies in clinical trials near you – page 30

603 trials match your criteria

Malignant melanoma stage IV+1

Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies

Small cell lung cancer extensive stage+2

Testing Tarlatamab in Patients with Advanced Small-Cell Lung Cancer Who Have Poor Physical Condition

Malignant melanoma

Study of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment

Chronic kidney disease+1

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Dermatitis atopic

Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis

Major depression

Study of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo

Metabolic dysfunction-associated liver disease+2

Comparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease

Endocrine ophthalmopathy

Study of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease

Fabry's disease

Study comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy

Urticaria chronic

Study of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria

Adenocarcinoma gastric+3

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Hereditary angioedema

Safety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.